These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A novel approach to the development of positive inotropic agents for chronic heart failure. Packer M J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S52-6. PubMed ID: 8907131 [TBL] [Abstract][Full Text] [Related]
3. Review: therapeutic concepts of congestive heart failure. Haustein KO Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):273-81. PubMed ID: 1974888 [TBL] [Abstract][Full Text] [Related]
4. [Mechanisms and clinical profile of inotropic action of medicines for heart failure]. Yazaki Y Kokyu To Junkan; 1989 Dec; 37(12):1271-7. PubMed ID: 2694254 [No Abstract] [Full Text] [Related]
5. [Treatment of chronic heart failure with positive inotropic agents]. Lechat P Therapie; 1989; 44(6):437-45. PubMed ID: 2576155 [TBL] [Abstract][Full Text] [Related]
6. [Positive inotropic agents in heart failure. Clinico-pharmacological evidence for medical practice]. Rohde LE; Ribeiro JP Arq Bras Cardiol; 1994 Dec; 63(6):537-42. PubMed ID: 7605243 [No Abstract] [Full Text] [Related]
7. [Use of inotropic agents in the treatment of cardiac insufficiency]. Coma Canella I; López-Sendón J Rev Esp Cardiol; 1984; 37(3):186-95. PubMed ID: 6150525 [No Abstract] [Full Text] [Related]
8. Strategy for the discovery and development of a positive inotropic agent. Evans DB; Weishaar RE; Kaplan HR Pharmacol Ther; 1982; 16(3):303-30. PubMed ID: 6127729 [No Abstract] [Full Text] [Related]
9. [New inotropic drugs]. Ferrari M; Cargnelli G; Piovan D; Bova S; Padrini R G Ital Cardiol; 1982; 12(2):139-46. PubMed ID: 6293904 [No Abstract] [Full Text] [Related]
10. [New inotropic agents in the treatment of congestive heart failure]. Freitas M Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458 [TBL] [Abstract][Full Text] [Related]
11. [Chronic left heart ventricle failure and inotropic stimulation]. Myhre ES; Gundersen T; Dickstein K; Hole T; Kjekshus J; Rønnevik P; Smith P; Westheim A Tidsskr Nor Laegeforen; 1995 Jan; 115(3):360-4. PubMed ID: 7855836 [TBL] [Abstract][Full Text] [Related]
12. New and old inotropic drugs: controversies and challenges, Oslo, Norway, May 21-22, 1982: reflections on inotropic drugs: a personal commentary. Storstein L; Taylor SH Clin Cardiol; 1984 Feb; 7(2):119-24. PubMed ID: 6142780 [No Abstract] [Full Text] [Related]
13. Pharmacology of bipyridine phosphodiesterase III inhibitors. Honerjäger P; Nawrath H Eur J Anaesthesiol Suppl; 1992; 5():7-14. PubMed ID: 1600969 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of calcium-sensitizing agents. Vegh A; Papp JG; Udvary E; Kaszala K J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S20-31. PubMed ID: 8907128 [TBL] [Abstract][Full Text] [Related]
18. [Positive inotropic substances. Possible use in heart failure in the aged]. Michel D Fortschr Med; 1991 Aug; 109(25):496-9. PubMed ID: 1937336 [TBL] [Abstract][Full Text] [Related]
19. The Na(+), K(+)-ATPase: more than just a sodium pump. Scheiner-Bobis G Cardiovasc Res; 2011 Jan; 89(1):6-8. PubMed ID: 21097805 [No Abstract] [Full Text] [Related]
20. [Treatment of heart failure: what--when--how?]. Blömer H Verh Dtsch Ges Inn Med; 1990; 96():157-67. PubMed ID: 2092435 [No Abstract] [Full Text] [Related] [Next] [New Search]